People News

Noravax, a clinical stage biotech focused on vaccines for infectious diseases, announced the appointment of John Trizzino as SVP, international and government alliances. Trizzino, previously vice president of MedImmune's vaccine franchise, will report directly to Noravax president and CEO Rahul Singhvi.


Media agency CMI announced three promotions: Lauren Santangelo and Jana Truax were both promoted from assistant media planner I to media planner I, and Brett Marvel was promoted from media planner I to media planner II.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel